USPTO serial 98514063
GENIALIS
Reviewed by CopyMark Law Group
Status 732Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- SWEENEY, MOLLY B
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with GENIALIS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $349*
Plus Government fees of $300
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Boston, MA, US
Boston, MA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Joshua S. Jarvis, Esq.
Joshua S. Jarvis, Esq. Foley Hoag LLP155 Seaport BoulevardSeaport WestBoston, MA 02210-2600Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable software as a medical device (SaMD) for the purposes of diagnosing, preventing, and treating cancer; downloadable electronic publications in the nature of reports in the field of drug development. | ACTIVE | — |
| 042 | Pharmaceutical research and development; scientific research and development, namely, inputting, collecting, defining, modeling, analyzing, and validating data related to gene signatures and biomarkers for the purposes of drug development; design, development, and implementation of software related to drug development; customizing software related to drug development; consulting services in the field of design and implementation of software for others in the field of drug development; consulting services for others in the field of design, planning, and implementation project management of scientific and pharmaceutical research; providing online non-downloadable software for accessing, viewing, analyzing, and sharing reports in the field of drug development and cancer diagnosis. | ACTIVE | Jul 17, 2019 |
| 045 | Licensing of intellectual property. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 14, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 13, 2026 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Jul 13, 2026 | EXT3 | SOU EXTENSION 3 FILED | — |
| Jul 13, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 8, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 7, 2026 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jan 7, 2026 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jan 7, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 13, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 12, 2025 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jun 12, 2025 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jun 12, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 14, 2025 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Dec 3, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 3, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 27, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 11, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 11, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 11, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 11, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 11, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 6, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 10, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 23, 2024 | NWAP | NEW APPLICATION ENTERED | — |